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http:WHAT THIS PAPER ADDS
This multidisciplinary approach targeted on the luminal surface brings together new engineering technologies to
established vascular graft development of small diameter vascular grafts. Results from this study conﬁrm the
potential of these surface modiﬁcation techniques for wider adoption forming the basis towards producing ‘self-
endothelialising’ vascular grafts, enhancing long-term patencies, and beneﬁtting vascular patients in the future.Introduction: Vascular graft materials in clinical use, such as polytetraﬂuoroethylene (PTFE) and Dacron, do not
endothelialise and have low patency rates. The importance of an endothelial cell layer on the luminal surface of a
vascular graft is well-known with surface topography and chemistry playing an important role. The aim of this
study was to investigate the potential of plasma treatment and topographical structures on the luminal graft
surface to enhance the self-endothelialisation potential of a nanocomposite vascular graft.
Methods: POSS-PCU is a polycarbonate urea urethane (PCU) with a nanoparticle, polyhedral oligomeric
silsesquioxane (POSS) incorporated within it. Planar, microgrooved, and nanopit patterned polymer ﬁlms were
fabricated using photolithography, electron beam lithography, reactive ion etching, and replication by solvent
casting. Films were then exposed to oxygen plasma treatment at different powers for a ﬁxed time (40W, 60W,
80W/60 seconds). Effects of plasma treatment were assessed using scanning electron microscopy, atomic force
microscopy and water contact angle analysis. Human umbilical vein endothelial cell (HUVEC) proliferation and
morphology were characterised using immunostaining, live/dead staining, and Coomassie blue staining.
Results: Successful embossing of the micro- and nanostructures was conﬁrmed. Oxygen plasma treatment of the
different samples showed that increasing power signiﬁcantly increased the hydrophilicity of the samples
(p < .0001). Improved HUVEC adhesion was seen on plasma modiﬁed compared with untreated samples
(p < .0001). Coomassie blue staining showed that after 5 days, cells started to form monolayers and live/dead
staining showed the cells were viable. Immunostaining showed that HUVECs expressed nitric oxide synthase on
all topographies with focal adhesions appearing more pronounced on nanopit surfaces, showing retention of
morphology and function.
Conclusion: These encouraging results indicate a future important role for plasma treatment and
nanotopography in the development of endothelialised vascular grafts.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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still suffer from early failure from thrombosis, and the
majority of these use polytetraﬂuorethylene (PTFE). A major
clinical trial conducted in Vienna showed the beneﬁts of an
endothelial layer within the luminal surface of PTFE grafts
implanted in the infrainguinal region.1 At 5 years, the pri-
mary patency rate for pre-seeded PTFE grafts was 78%
compared with previous studies which showed 49e57.4%
patencies at 5 years for infrainguinal vascular grafts.2,3
Despite these encouraging results, the logistics of pre-
seeding still hamper wider usage of this technique. The
main problems are the length of time taken to
336 D.S.T. Chong et al.‘endothelialise’ the grafts, the need for specialised cell
culture facilities, and invasive procedures to harvest cells
from patients. Integrated provision of cell culture facilities
and operating theatres limit this method to university or
specialist hospitals.
POSS-PCU is a novel nanocomposite polymer, which has
been developed as a vascular bypass graft material, and is
composed of a nanoparticle, polyhedral oligomeric silses-
quioxane (POSS), and polycarbonate urea urethane (PCU).
The beneﬁcial effects of the nanoparticle when combined
with the polyurethane-based polymer include its antith-
rombogenicity and mechanical properties allowing it to be
compliant while retaining strength.4e6 Despite these ad-
vantages, recent large animal studies conducted to Good
Laboratory Practice (GLP) standards, have shown that after
insertion as a carotid interposition graft and subsequent
explantation there is an incomplete endothelialisation
within the graft.7 This raises concern in terms of the long-
term patency potential of the graft and has led us to
consider other techniques and methods that may promote
endothelialisation.
The ability to inﬂuence inward migration of vascular
endothelial cells (ECS) from the neighbouring vessel
resulting in endothelialisation offers an exciting prospect.
However, scepticism arose when it was noted that in PTFE
and Dacron grafts the inward migration is never more than
2e3 cm and initial enthusiasm quickly wavered.8 However,
advances in technology, namely plasma modiﬁcation and
surface patterning, have renewed interest in this approach
to self-endothelialisation.
Surface chemistry is known to play an important part in
the responsiveness of cells to biomaterials. Plasma treat-
ment has been used to help enhance surface chemistry by
incorporating chemical groups into the material that are
known to enhance cell attachment, such as eOH, eNH2,
and eCOOH groups, lowering the water contact angle
(WCA) of the material. O2 plasma technology produces a
mixture of eOH and eCOOH groups on the polymeric
surfaces optimising surface hydrophilicity thus providing a
more conducive surface to cell attachment and spreading.
Furthermore it is believed that uncharged moderately hy-
drophilic surfaces have the potential beneﬁt of low levels of
interaction with plasma, proteins, and blood.9 Plasma
treatment has several potential advantages over other
methods of surface chemical modiﬁcation such as wet
chemical treatments e it is solvent-free, conserves the
original mechanical properties of the bulk material, and
uniformly changes the surface chemistry.10
The modulation of surface structures to provide bio-
physical cues to ECs has been an area of recent focus.11
Surface topography works synergistically with surface
chemistry to provide the cell with instructional cues to
modify cell behaviours.
Emerging technologies such as nanotechnology and
nanoengineering have shown initial promise in providing
biophysical cues at the micro- and nanoscale to cells that
inﬂuence cellular migration, differentiation, and adhe-
sion.12e14 Surface material structuring techniques used inthe life sciences have been borrowed from the semi-
conductor industry and these technologies enable the
production and optimisation of their fabrication.15 Electron
beam lithography (EBL) and photolithography (PL) fabrica-
tion techniques (Fig. 1) have been widely used in the en-
gineering industry and remain the ‘standard’ for producing
ordered micro- and nanostructured surfaces.16 Over the last
10 years, these techniques have been modiﬁed for use in
the biomedical devices industry, including the production of
vascular devices.11 A topography of particular interest over
the last few years has been the near-square 50 (NSQ) sur-
face that has been demonstrated to increase mesenchymal
stem cell adhesion and function.13,14,17 It comprises 120 nm
diameter pits (100 nm deep) in a square lattice. The pits are
placed with 300 nm centre-centre spacing but with up to
50 nm offset from the true centre, that is it is deliberately
disordered rather than random.
Thus surface modulation of the vascular graft to promote
endothelialisation is now an important aspect of vascular
engineering technologies. Understanding the role of both
surface topography and chemistry in endothelial cell
biology is an integral part to engineering the luminal sur-
face. In this study, the synergistic role of surface topography
and chemistry is investigated in promoting endothelialisa-
tion within a nanocomposite vascular graft material.
MATERIALS AND METHODS
Cell culture
Human umbilical vein endothelial cells (Life Technologies,
UK) (HUVECs) were cultured in M200 media supplemented
with Low Serum Growth Serum (Life Technologies, UK) and
for experiments, cells were used between passages 3 and 6.POSS-PCU preparation
Preparation of the POSS-PCU polymer has been reported
extensively.4 In brief, polycarbonate diol and trans-
cyclohexanechlorohydrinisobutyl-POSS were added to a re-
action vessel then heated to 130 C while being stirred
under nitrogen gas. The reactants were then cooled before
4,40-methylenebis(phenyl isocyanate) (MDI) was added and
all components reacted for 30 minutes under nitrogen gas.
This reaction then forms a prepolymer before dimethyla-
cetamide (DMAC) was added to convert this prepolymer
into a solution. This solution was then cooled before the
chain extender, ethylenediamine, was added dropwise until
the reaction was completed. The chain stopper, 1-butanol,
was then used to prevent further unwanted polymerisation.
All of the reagents were supplied by Sigma Aldrich (Dorset,
UK) and used as provided with the exception of POSS, which
was supplied by Hybrid Plastics Inc (Mississippi, USA).Fabrication of planar, micro- and nanostructured POSS-
PCU substrates
Microgroove (MG) and nanopit (NP, i.e. NSQ) silicon mas-
ters were fabricated via photolithography and electron
beam lithography (EBL), respectively, followed by reactive
Figure 1. Fabrication of patterned POSS-PCU. Schematic diagrams detailing the fabrication process used to generate topographically
patterned POSS-PCU ﬁlms. (A) Silicon masters were initially fabricated using photolithography or electron beam lithography (for micron
scaled grooved or nano scaled pit substrates, respectively). In this work, microgrooved substrates were patterned into glass. (B) Masters
were used to directly pattern POSS-PCU ﬁlms using soft lithography. (C) Scanning electron micrograph showing nanopillars fabricated using
electron beam lithography with metal on top of each pillar (samples were imaged before metal removal).
Nanotopography and Plasma Treatment 337ion etching (Fig. 1) as described previously.13,18 The groove
and pit patterned substrates topographies were transferred
into POSS-PCU polymer ﬁlms using soft lithography, spe-
ciﬁcally solvent casting. Initially the POSS-PCU-DMAC solu-
tion was poured onto the silicon masters and placed into a
vented oven set to 60 C. After 3e9 hours, during which
time the DMAC solvent evaporated from the cast ﬁlm,
POSS-PCU ﬁlms were peeled from the master surface. Sol-
vent casting resulted in the production of three POSS-PCU
substrates, namely: planar (P), microgrooved (MG), and
nanopitted (NP) (Fig. 3A). MG ﬁlm features consisted of
12.5 mm wide grooves, with 25 mm pitch and 700 nm
groove depth. NP ﬁlm features consisted of 120 nm diam-
eter pits, with 300 nm pitch and a random offset from
square arranged lattice centre of up to 50 nm.Plasma treatment of POSS-PCU
POSS-PCU ﬁlms were plasma treated in a barrel-type plasma
asher (Plasma Prep 5 GaLa Instrumente) with O2 at differentpowers (40W, 60W, 80W) for a ﬁxed period of time
(60 seconds) in a cleanroom. Low pressure and a pure ox-
ygen gas environment promotes plasma formation when a
RF generated electric ﬁeld is produced across the chamber
causing an ionised gas to form (i.e. plasma), which chemi-
cally and physical reacts with the substrate surface typically
resulting in the introduction of oxygen-rich chemical groups
such as hydroxyls and carboxyls. Post plasma treatment,
water contact angle (WCA) was measured (using apparatus
assembled in-house). WCA is a good indication of the suc-
cess of the plasma treatment on the polymer and conﬁrms
the level hydrophilicity attained.Scanning electron microscopy (SEM) and atomic force
microscopy (AFM)
Samples were processed with a sputter-coating of gold at a
thickness of 2 nm. SEM analysis was carried out using a Carl
Zeiss Sigma Variable Pressure Analytical SEM with Oxford
Microanalysis (Germany). AFM measurements and analysis
338 D.S.T. Chong et al.was conducted using a Nanowizard 3 (JPK Instruments,
Berlin, Germany). These measurements give us an accurate
representation of the feature sizes. Root mean square
(RMS) values were also taken from these AFM measure-
ments as a representative of surface roughness. RMS values
were also taken for both plasma treated (80W at 60s) and
non-plasma treated planar samples for comparison with the
treated and non-treated NP samples.
Live/dead staining
Live/dead staining was performed using the LIVE/DEAD
Viability/Cytotoxicity kit for mammalian cells (L-3224, Invi-
trogen). Brieﬂy, calcein AM and ethidium homodimer-1
were made up to concentrations of 2 mM and 4 mM,
respectively, using phosphate buffered saline (PBS). These
solutions were incubated with the day 5 samples for
30 minutes at 37 C, before washing samples with PBS then
analysing with a ﬂuorescence microscope (Zeiss Axiovert
M200).
Immunostaining
The immunostaining methodology has been described
previously.19 Day 5 samples were ﬁxed in 4% formaldehyde
for 15 minutes at 37 C then washed before placing in
permeabilising buffer and blocking in 1% (w/v) bovine
serum albumin/PBS. Samples were then stained with anti-
vinculin antibody (1:150) (Sigma) in 1% (w/v) BSA/PBS or
anti endothelial nitric oxide synthase (eNOS) antibody
(1:50), in conjunction with rhodamine/phalloidin (1:500),
and incubated at 37 C for 1 hour. Samples were subse-
quently washed 3  5 minutes (0.5% Tween-20 in PBS) and
then the secondary antibody, which was biotinylated, was
added (Vector Laboratories) at 1:50 in 1%(w/v) BSA/PBS.
Samples were then incubated for 1 hour at 37 C. After
further washing, FITC-conjugated streptavidin (1:50, Vector
Laboratories) was added and incubated for a further
30 minutes at 4 C. Samples were given a ﬁnal wash before
mounting using Vectashield with DAPI nuclear stain (VectorFigure 2. Chemical modiﬁcation of POSS-PCU ﬁlms using oxygen plasma
were placed in a plasma generator where oxygen plasma, created by e
(RF) powered electric ﬁeld, was produced for a set period of time. (B) In
water contact angle measurement highlighted (q) in red. Main chart s
treatment for increasing times. Statistically signiﬁcant differences are hiLaboratories). Samples were imaged using ﬂuorescence
microscopy (Zeiss Axiovert M200).
Coomassie blue staining
Day 5 samples were ﬁxed using 4% formaldehyde then
stained with Coomassie blue (0.2% Coomassie blue w/v in
46.5% methanol, 7% acetic acid, 46.5% water) for 2 mi-
nutes. Samples were subsequently washed with deionised
water before being visualised using optical microscopy.
Cell number
Cell numbers were measured after 5 days of culture by
taking ﬂuorescence microscope images, at a magniﬁcation
of 20, of cells stained with DAPI. Cell nuclei were counted
as an indicator of cell number. Images were taken at
random locations on the substrates; ten locations were
imaged on each ﬁlm, and a minimum of six ﬁlms were
assessed for each treatment type.
Statistics
All statistical calculations were conducted using Prism
(GraphPad Software, La Jolla, USA).
Statistical analyses were carried out on data as follows:
water contact angle data sets were compared using a Krus-
kaleWallis one-way analysis of variance (non-parametric)
test, roughness values between sample types were compared
using ManneWhitney (non-parametric) tests, differences in
cell numbers between samples (both plasma treated planar
substrates and topographically patterned substrates) were
compared using KruskaleWallis (non-parametric) tests.
RESULTS
Plasma treatment promoted surface hydrophilicity and
lowered the water contact angle. Increasing the power of
plasma treatment over a short time period of 60 seconds at
a constant pressure of 0.24 mBar, lowered the WCA in a
stepwise manner (Fig. 2). There was no signiﬁcant. (A) Schematic illustration of plasma treatment apparatus. Samples
xposing pure oxygen gas at precise pressure to a radio frequency
set photograph shows a drop of water on a POSS-PCU ﬁlm with its
hows water contact angles of POSS-PCU ﬁlms after oxygen plasma
ghlighted on the graph as follows: **** (p < .0001), *** (p < .001).
Figure 3. Substrate characterisation. (A) Scanning electron microscopy images of planar, microgrooved, and nanopit surfaces before plasma
treatment, insets show higher magniﬁcation images of topographies; nanopit inset was imaged after plasma modiﬁcation for 80 seconds.
(B) AFM scans of planar (upper two images) and nanopit (lower two images) POSS-PCU ﬁlms before (left hand side images) and after (right
hand side images) plasma treatment. (C) Box plot showing roughness values of planar and nanopit POSS-PCU ﬁlms before and after plasma
treatment. No signiﬁcant differences between samples types were observed.
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(data not shown). There was a signiﬁcant difference be-
tween untreated POSS-PCU and all plasma treatments, and
signiﬁcant differences between each step increase in
plasma power.
Replication ﬁdelity of manufacture of both micro- and
nanoscale features was conﬁrmed by AFM and SEM images
and shows that at higher plasma treatments, disruption of
the NP topographies are not seen (Fig. 3). The inherent
properties of POSS-PCU are shown by the aggregation of
POSS nanoparticles on the surface of the polymer and these
do not disrupt the embossing of either the micro- or
nanopatterns on the polymer.
RMS results showed that there was no statistical differ-
ence between treated and non-treated samples for either P
or NP substrates. Taken together with visual observations,
these measurements demonstrate that plasma treatment
did not signiﬁcantly affect topographic surface features.
Surface roughness is an important consideration, not only
as an indicator of pattern ﬁdelity after plasma treatment,
but also because increases in surface roughness can have
effects on WCAs and thus hydrophilicity. In this case, the
RMS values indicated that surface roughness was notsigniﬁcant enough to play an additional role in determining
the WCA of the substrate, and that the main controlling
factor would be the plasma treatment.
Quantiﬁcation of cell numbers compared with a control
polycarbonate urethane polymer (PCU), conﬁrmed a sig-
niﬁcant increase in cell numbers on all plasma-modiﬁed
samples. These are encouraging results as PCU is currently
in clinical use for vascular grafts, although lesser known
than PTFE, and is related in formulation to POSS-PCU.
Increasing cell numbers were observed with increasing
plasma treatment, with very few cells observed on the
untreated POSS-PCU substrates. The most cell growth was
observed with the 80W plasma treatment, although there
was no signiﬁcant difference between the treatment times
of 60W and 80W. These observations highlight the impor-
tance of surface chemistry for HUVEC adhesion to POSS-
PCU substrates. Plasma modiﬁcation is conﬁrmed to be a
reliable methodology for optimising the surface of POSS-
PCU substrates favouring endothelial cell adherence and
growth with a plasma treatment of 80W for 60 seconds
being optimal for HUVECs.
When evaluating the response of HUVECs to the different
topographies (plasma treated at 80W), it is noted that there
340 D.S.T. Chong et al.was no signiﬁcant difference in cell numbers although there
does appear to be a slightly higher cell number on NP
compared with P and MG substrates (Fig. 4B). Live/dead
staining of the HUVECs showed viable cells on all three of
the substrates (Fig. 4C), showing the viability of the HUVECs
on treated substrates regardless of surface topographies.
Further Coomassie blue (Fig. 4C) staining of the samples at
5 days revealed the start of endothelial monolayer forma-
tion across the surface of the substrates independent of
topographies (Fig. 4C). This ‘patchy’ adhesion follows the
initial cellular adhesion and proliferation of HUVECs typi-
cally observed.
Immunostaining of the cells further demonstrated the
avidity of the modiﬁed substrates for cell adhesion (Fig. 5).
Staining revealed the presence of prominent focal adhe-
sions on the NP surface at high magniﬁcation. Focal adhe-
sions were not seen as prominently on the P or MG
surfaces, suggesting that nanotopography plays a subtle but
important part in cellular adhesion. The expression of
endothelial nitric oxide synthase (eNOS) is important as aFigure 4. Cell proliferation on modiﬁed POSS-PCU ﬁlms. (A) Box
plot showing cell numbers on plasma modiﬁed POSS-PCU ﬁlms and
unmodiﬁed POSS-PCU (0) and PCU ﬁlms. Signiﬁcant differences are
highlighted on the graph as follows: **** (p < .0001), ***
(p < .001), ** (p < .01). (B) Chart detailing cell numbers on plasma
treated (80 watts for 60 seconds) POSS-PCU ﬁlms with differing
topographies. No signiﬁcant differences were observed between
sample types. (C) Upper image shows a scan of Coomassie blue
stained cells on topographically patterned ﬁlms. Lower image
shows ﬂuorescently labelled cells (green ¼ live, red ¼ dead) on a
nanopit patterned substrate treated at 80 watts for 60 seconds.
NP ¼ nanopit, MG ¼ microgrooved.marker of endothelial cell function.20 The presence of eNOS
in all the samples, as shown in the immunostaining images,
is a good indicator that endothelial cell function is main-
tained (Fig. 5B).DISCUSSION
Off-the-shelf small diameter vascular grafts (<6 mm luminal
diameter) with patency rates at least equivalent to autol-
ogous vessel remains an unmet goal in vascular surgery.
Currently approaches of either improving on current ma-
terials in clinical use, PTFE and Dacron, or development of
new materials are all being explored.21,22 The main
emphasis of this research is to develop a vascular graft with
‘off-the-shelf’ capacity and the ability to have ‘self-endo-
thelialisation’ potential while maintaining all the mechanical
properties of being biocompatible, compliant, and non-
thrombogenic. This eliminates cumbersome ‘pre-seeding’
with endothelial cells, and therefore potentially allows the
use of this graft without the need for special facilities in
routine and emergency bypass surgery, and in any vascular
or cardiothoracic clinic.
Polyurethane-based vascular bypass materials were once
thought to be superior to PTFE and Dacron, but, unfortu-
nately, were plagued by post-implantation aneurysmal for-
mation because of poor biostability.23 Chemical modulation
of polyurethanes has resulted in the development of bio-
stable polymers such as PCU, and with the incorporation of
POSS nanoparticles improved mechanical strength,
modulus, and rigidity.24
Oxygen plasma treatment increased both the hydrophi-
licity of the POSS-PCU surface and subsequent HUVEC
growth. Increasing plasma treatment intensity decreased
the WCAs and thus increased hydrophilicity of the POSS-
PCU substrates in a step-wise manner, facilitating HUVEC
growth. Plasma treatment has been used by other research
groups for surface chemical modulation to induce a more
cytophilic response (e.g. for endothelialisation).25 However,
use of plasma treatment alone may not be enough,26
especially as there may be a more subtle role that is
played by surface topography. This suggests that a syner-
gistic role may be played by incorporating both treatment
approaches, as has been suggested by other authors.27
Nanoscale topography in the form of nanopits (NSQ)
appeared to promote focal adhesion formation over planar
(P) and microscale topography (MG). This is an interesting
observation as it indicates that nanoscale topographical
features may play an important but subtle role in endo-
thelial cell adhesion. However, it must be noted that there
were no signiﬁcant differences between HUVEC prolifera-
tion on the different topographies. It is not known whether
modulation of nanoscale features will favour more focal
adhesion formation thus promoting stronger EC adhesion as
a separate factor to proliferation - this possibility merits
further investigation. The presence of eNOS expression by
the HUVECs on the substrates is extremely encouraging as
this illustrates that function was retained by the ECs. The
importance of eNOS expression and nitric oxide production
Figure 5. Cell morphology and function on topographically patterned POSS-PCU ﬁlms. Fluorescent micrographs show nuclei (blue) and
actin (red). Speciﬁc proteins, namely vinculin (highlights focal adhesions at cell periphery) and endothelial nitric oxide synthase (marker of
endothelial cell function) are highlighted in red in (A) and (B), respectively. Grey arrows on the lower right image in (A) highlight focal
adhesions. Images were enhanced using brightness/contrast controls with the exception of insets in (B), which show unmodiﬁed images of
eNOS expression taken using identical microscope settings.
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regulation, decreasing platelet aggregation, and beneﬁcial
effects on vascular micro-circulations.28
This work has been conducted on a static in vitro system,
with improved cellular adhesion so that the fundamental
objective is that cells are subsequently able to withstand
the forces exerted within a dynamic ﬂow system. In over
85% of studies in the literature, it has been shown that
cellular adhesion to the substrate under static conditions is
an important factor when it comes to being able to with-
stand cellular detachment from the vascular graft sur-
face.29e31 The combined approach of using oxygen plasma
treatment to increase hydrophilicity and topographical
changes to optimise cell attachment and behaviour, allows amore controlled approach to luminal surface engineering.
These techniques avoid the use of bonded proteins and
peptides, which have traditionally been the main focus of
surface modulation, and therefore problems with high cost,
coating delamination, and increased regulatory hurdles.
When cultured on microgrooves, ﬂow only detached 8% of
cells compared with 42% on ﬂat surfaces; in another study,
nanopatterns enhanced adhesion from 37% to 91%.32
Furthermore, presentation of topography and ﬂow,
respectively, has signiﬁcant impact on EC alignment and
migration, indicating a synergistic role between the bio-
physical cues.33 Therefore, further work will focus further
on surface optimisation, in particular on interactions with
proteins (e.g. protein adsorption), inﬂammatory cells, and
342 D.S.T. Chong et al.blood components (e.g. platelets), and as a ﬁnal step most
importantly both under static and haemodynamic ﬂow
conditions.
Although still in its infancy, this methodology merits
greater research focus in surface modulation of vascular
graft materials with ‘self-endothelialisation’ potential. The
results of this study conﬁrm the potential to modify a
vascular graft surface using a combination of plasma
treatment and surface topography to promote HUVEC
adhesion in an otherwise ‘non-adhesive’ polymer. Control of
EC adhesion and spreading via surface topography and
chemistry is a precise methodology, which has an important
potential role in future vascular graft engineering.CONFLICT OF INTEREST
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